ANGIODYNAMICS INC (ANGO) Stock Price, Forecast & Analysis
USA - NASDAQ:ANGO - US03475V1017 - Common Stock
ANGO Key Statistics, Chart & Performance
The current stock price of ANGO is 12.02 USD. In the past month the price increased by 9.27%. In the past year, price increased by 66.94%.
ANGO Latest News, Press Relases and Analysis
ANGO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.32 | 219.92B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.04 | 200.75B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.91 | 148.20B | ||
| SYK | STRYKER CORP | 27.03 | 136.11B | ||
| IDXX | IDEXX LABORATORIES INC | 56.18 | 56.68B | ||
| BDX | BECTON DICKINSON AND CO | 12.33 | 50.97B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.45 | 48.96B | ||
| RMD | RESMED INC | 25.4 | 36.70B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.92 | 33.35B | ||
| PODD | INSULET CORP | 69.98 | 22.51B | ||
| DXCM | DEXCOM INC | 29.57 | 21.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.94 | 17.53B |
Related stock screener links
About ANGO
Company Profile
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 675 full-time employees. The company went IPO on 2004-05-27. The firm is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. The company designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Company Info
ANGIODYNAMICS INC
14 Plaza Drive
Latham NEW YORK 12110 US
CEO: James C. Clemmer
Employees: 748
Phone: 15187981215
ANGIODYNAMICS INC / ANGO FAQ
What does ANGO do?
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 675 full-time employees. The company went IPO on 2004-05-27. The firm is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. The company designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
What is the current price of ANGO stock?
The current stock price of ANGO is 12.02 USD. The price increased by 2.47% in the last trading session.
What is the dividend status of ANGIODYNAMICS INC?
ANGO does not pay a dividend.
What is the ChartMill rating of ANGIODYNAMICS INC stock?
ANGO has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the Price/Earnings (PE) ratio of ANGIODYNAMICS INC (ANGO)?
ANGIODYNAMICS INC (ANGO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.14).
How many employees does ANGIODYNAMICS INC have?
ANGIODYNAMICS INC (ANGO) currently has 748 employees.
What is the market capitalization of ANGO stock?
ANGIODYNAMICS INC (ANGO) has a market capitalization of 495.22M USD. This makes ANGO a Small Cap stock.
ANGO Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ANGO. When comparing the yearly performance of all stocks, ANGO is one of the better performing stocks in the market, outperforming 93.56% of all stocks.
ANGO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ANGO. Both the profitability and financial health of ANGO have multiple concerns.
ANGO Financial Highlights
Over the last trailing twelve months ANGO reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS increased by 63.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.08% | ||
| ROE | -17.95% | ||
| Debt/Equity | 0.03 |
ANGO Forecast & Estimates
10 analysts have analysed ANGO and the average price target is 18.87 USD. This implies a price increase of 56.99% is expected in the next year compared to the current price of 12.02.
For the next year, analysts expect an EPS growth of -124.4% and a revenue growth 8.22% for ANGO